Tags » Bisphosphonates
Osteoporosis is marked by loss of bone tissue and low bone mass leading to major physiological changes rendering it porous and brittle. It is a major health concern in developed countries, affecting 30% of women especially during postmenopausal age and 20% of men worldwide. 348 more words
Osteoporosis is a systemic skeletal disorder characterized by bone loss, which leads to impaired bone strength and an increased risk of fractures. Two million fractures are attributed to osteoporosis annually in the United States and they are associated with serious morbidity and mortality. 124 more words
Bisphosphonate therapy was effective for reducing fracture incidence among postmenopausal women with diabetes, a post hoc analysis of randomized trial data found.
Among women with diabetes, the relative risk of nonvertebral fracture was 0.52 (95% CI 0.33-0.80) and the relative risk of morphometric vertebral fracture was 0.34 (95% CI 0.18-0.67), reported… 421 more words
Every month, JBJS publishes a Specialty Update—a review of the most pertinent and impactful studies published in the orthopaedic literature during the previous year in 13 subspecialties. 658 more words
The Journal of Bone and Mineral Research recently published a study that examines effects of media reports on the use of oral bisphosphonates. Google trends were utilized to get data from 1996 to 2012 for the media reports; the Medical Expenditure Panel Survey and the National Inpatient Sample were used to obtain data regarding fracture outcomes in the United States. 194 more words